Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""neutralization"" wg kryterium: Temat


Tytuł:
Immunogenicity and safety of RAZI recombinant spike protein vaccine (RCP) as a booster dose after priming with BBIBP-CorV: a parallel two groups, randomized, double blind trial.
Autorzy:
Erfanpoor, Saeed (AUTHOR)
Banihashemi, Seyed Reza (AUTHOR)
Mokhbaeralsafa, Ladan (AUTHOR)
Kalantari, Saeed (AUTHOR)
Es-haghi, Ali (AUTHOR)
Nofeli, Mojtaba (AUTHOR)
Rezaei Mokarram, Ali (AUTHOR)
Sadeghi, Fariba (AUTHOR)
Hajimoradi, Monireh (AUTHOR)
Razaz, Seyad Hossein (AUTHOR)
Taghdiri, Maryam (AUTHOR)
Lotfi, Mohsen (AUTHOR)
Khorasani, Akbar (AUTHOR)
Ansarifar, Akram (AUTHOR)
Masoumi, Safdar (AUTHOR)
Mohazzab, Arash (AUTHOR)
Filsoof, Sara (AUTHOR)
Mohseni, Vahideh (AUTHOR)
Shahsavan, Masoumeh (AUTHOR)
Gharavi, Niloufar (AUTHOR)
Pokaż więcej
Źródło:
BMC Medicine. 2/20/2024, Vol. 22 Issue 1, p1-11. 11p.
Czasopismo naukowe
Tytuł:
Differential laboratory passaging of SARS-CoV-2 viral stocks impacts the in vitro assessment of neutralizing antibodies.
Autorzy:
Avila-Herrera A; Lawrence Livermore National Laboratory, Computing Directorate, Global Security Computing Applications Division, Livermore, California, United States of America.
Kimbrel JA; Lawrence Livermore National Laboratory, Physical and Life Sciences Directorate, Biosciences and Biotechnology Division, Livermore, California, United States of America.
Manuel Martí J; Lawrence Livermore National Laboratory, Computing Directorate, Global Security Computing Applications Division, Livermore, California, United States of America.
Thissen J; Lawrence Livermore National Laboratory, Physical and Life Sciences Directorate, Biosciences and Biotechnology Division, Livermore, California, United States of America.
Saada EA; Lawrence Livermore National Laboratory, Physical and Life Sciences Directorate, Biosciences and Biotechnology Division, Livermore, California, United States of America.
Weisenberger T; Lawrence Livermore National Laboratory, Physical and Life Sciences Directorate, Biosciences and Biotechnology Division, Livermore, California, United States of America.
Arrildt KT; Lawrence Livermore National Laboratory, Physical and Life Sciences Directorate, Biosciences and Biotechnology Division, Livermore, California, United States of America.
Segelke BW; Lawrence Livermore National Laboratory, Physical and Life Sciences Directorate, Biosciences and Biotechnology Division, Livermore, California, United States of America.
Allen JE; Lawrence Livermore National Laboratory, Computing Directorate, Global Security Computing Applications Division, Livermore, California, United States of America.
Zemla A; Lawrence Livermore National Laboratory, Computing Directorate, Global Security Computing Applications Division, Livermore, California, United States of America.
Borucki MK; Lawrence Livermore National Laboratory, Physical and Life Sciences Directorate, Biosciences and Biotechnology Division, Livermore, California, United States of America.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2024 Jan 25; Vol. 19 (1), pp. e0289198. Date of Electronic Publication: 2024 Jan 25 (Print Publication: 2024).
Typ publikacji:
Journal Article
MeSH Terms:
Antibodies, Neutralizing*
COVID-19*
Humans ; SARS-CoV-2/genetics ; Antibodies, Viral ; Neutralization Tests ; Immune Sera ; Spike Glycoprotein, Coronavirus/genetics
Czasopismo naukowe
Tytuł:
Multicentric evaluation of sensitivity of eight commercial anti-SARS-CoV-2 antibody assays and their correlation to virus neutralization titers in seropositive subjects.
Autorzy:
Fajfr M; Institute of Clinical Microbiology, University Hospital in Hradec Kralove, Sokolska 581, Hradec Kralove, 50005, Czech Republic.; Faculty of Medicine in Hradec Kralove, Charles University, Hradec Kralove, Czech Republic.
Pajer P; Military Health Institute, Prague, Czech Republic.
Ruzek D; Department of Virology, Veterinary Research Institute, Brno, Czech Republic.; Institute of Parasitology, Biology Centre of the Czech Academy of Sciences, Ceske Budejovice, Czech Republic.; Department of Experimental Biology, Faculty of Science, Masaryk University, Brno, Czech Republic.
Sleha R; Department of Epidemiology, Military Faculty of Medicine, University of Defence, Hradec Kralove, Czech Republic.
Janovska S; Department of Epidemiology, Military Faculty of Medicine, University of Defence, Hradec Kralove, Czech Republic.
Bohonek M; Department of Hematology and Blood Transfusion, Military University Hospital Prague, Praha, Czech Republic.; Faculty of Biomedical Engineering, Czech Technical University in Prague, Prague, Czech Republic.
Kabickova H; Military Health Institute, Prague, Czech Republic.
Kubicková P; Military Health Institute, Prague, Czech Republic.
Stefanik M; Department of Virology, Veterinary Research Institute, Brno, Czech Republic.; Department of Hematology and Blood Transfusion, Military University Hospital Prague, Praha, Czech Republic.
Strakova P; Department of Virology, Veterinary Research Institute, Brno, Czech Republic.; Institute of Parasitology, Biology Centre of the Czech Academy of Sciences, Ceske Budejovice, Czech Republic.; Department of Experimental Biology, Faculty of Science, Masaryk University, Brno, Czech Republic.
Bostik P; Institute of Clinical Microbiology, University Hospital in Hradec Kralove, Sokolska 581, Hradec Kralove, 50005, Czech Republic. .; Faculty of Medicine in Hradec Kralove, Charles University, Hradec Kralove, Czech Republic. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2024 Jan 16; Vol. 14 (1), pp. 1421. Date of Electronic Publication: 2024 Jan 16.
Typ publikacji:
Journal Article
MeSH Terms:
SARS-CoV-2*
COVID-19*/diagnosis
Humans ; Serologic Tests/methods ; Sensitivity and Specificity ; Antibodies, Viral ; Immunoglobulin G ; Neutralization Tests/methods ; Antibodies, Neutralizing
SCR Organism:
SARS-CoV-2 variants
Czasopismo naukowe
Tytuł:
Neutralizing Antibody Response to Genotypically Diverse Measles Viruses in Clinically Suspected Measles Cases.
Autorzy:
Vaidya SR; ICMR-National Institute of Virology, 20-A, Dr. Ambedkar Road, Pune 411001, India.
Kumbhar NS; ICMR-National Institute of Virology, 20-A, Dr. Ambedkar Road, Pune 411001, India.
Andhare GK; ICMR-National Institute of Virology, 20-A, Dr. Ambedkar Road, Pune 411001, India.
Pawar N; ICMR-National Institute of Virology, 20-A, Dr. Ambedkar Road, Pune 411001, India.
Walimbe AM; ICMR-National Institute of Virology, 20-A, Dr. Ambedkar Road, Pune 411001, India.
Kinikar M; Bioinformatics Centre, Savitribai Phule Pune University, Pune 411007, India.
Kasibhatla SM; Bioinformatics Centre, Savitribai Phule Pune University, Pune 411007, India.; HPC-Medical and Bioinformatics Applications Group, Centre for Development of Advanced Computing, Panchavati, Pashan, Pune 411008, India.
Kulkarni-Kale U; Bioinformatics Centre, Savitribai Phule Pune University, Pune 411007, India.
Pokaż więcej
Źródło:
Viruses [Viruses] 2023 Nov 10; Vol. 15 (11). Date of Electronic Publication: 2023 Nov 10.
Typ publikacji:
Journal Article
MeSH Terms:
Antibodies, Neutralizing*
Measles*
Humans ; Antibodies, Viral ; Neutralization Tests ; Measles virus/genetics ; Measles Vaccine ; Epitopes ; Immunoglobulin M
Czasopismo naukowe
Tytuł:
Validation of a SARS-CoV-2 Surrogate Neutralization Test Detecting Neutralizing Antibodies against the Major Variants of Concern.
Autorzy:
Santos da Silva E; Department of Infection and Immunity, Luxembourg Institute of Health, 29 Rue Henri Koch, L-4354 Esch-sur-Alzette, Luxembourg.
Servais JY; Department of Infection and Immunity, Luxembourg Institute of Health, 29 Rue Henri Koch, L-4354 Esch-sur-Alzette, Luxembourg.
Kohnen M; National Service of Infectious Diseases, Centre Hospitalier de Luxembourg, 4 Rue Ernest Barblé, L-1210 Luxembourg, Luxembourg.
Arendt V; National Service of Infectious Diseases, Centre Hospitalier de Luxembourg, 4 Rue Ernest Barblé, L-1210 Luxembourg, Luxembourg.
Staub T; National Service of Infectious Diseases, Centre Hospitalier de Luxembourg, 4 Rue Ernest Barblé, L-1210 Luxembourg, Luxembourg.
The Con-Vince Consortium
The CoVaLux Consortium
Krüger R; Transversal Translational Medicine, Luxembourg Institute of Health, Centre Hospitalier de Luxembourg, 4 rue Ernest Barblé, L-1210 Luxembourg, Luxembourg.; Translational Neuroscience, Luxembourg Centre for Systems Biomedicine, University of Luxembourg, 6 avenue du Swing, L-4367 Belvaux, Luxembourg.
Fagherazzi G; Department of Precision Health, Luxembourg Institute of Health, 1AB Rue Thomas Edison, L-1445 Strassen, Luxembourg.
Wilmes P; Systems Ecology Group, Luxembourg Centre for Systems Biomedicine, 7 Avenue des Hauts Fourneaux, L-4362 Esch-sur-Alzette, Luxembourg.; Department of Life Sciences and Medicine, Faculty of Science, Technology and Medicine, University of Luxembourg, 6, Avenue du Swing, L-4367 Belvaux, Luxembourg.
Hübschen JM; Department of Infection and Immunity, Luxembourg Institute of Health, 29 Rue Henri Koch, L-4354 Esch-sur-Alzette, Luxembourg.
Ollert M; Department of Infection and Immunity, Luxembourg Institute of Health, 29 Rue Henri Koch, L-4354 Esch-sur-Alzette, Luxembourg.
Perez-Bercoff D; Department of Infection and Immunity, Luxembourg Institute of Health, 29 Rue Henri Koch, L-4354 Esch-sur-Alzette, Luxembourg.
Seguin-Devaux C; Department of Infection and Immunity, Luxembourg Institute of Health, 29 Rue Henri Koch, L-4354 Esch-sur-Alzette, Luxembourg.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2023 Oct 06; Vol. 24 (19). Date of Electronic Publication: 2023 Oct 06.
Typ publikacji:
Journal Article
MeSH Terms:
Antibodies, Neutralizing*
COVID-19*
Humans ; Neutralization Tests ; SARS-CoV-2 ; Breakthrough Infections ; Antibodies, Viral
Czasopismo naukowe
Tytuł:
Evolution of HIV-1 envelope towards reduced neutralization sensitivity, as demonstrated by contemporary HIV-1 subtype B from the United States.
Autorzy:
Wieczorek L; U.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America.; Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, Maryland, United States of America.
Sanders-Buell E; U.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America.; Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, Maryland, United States of America.
Zemil M; U.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America.; Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, Maryland, United States of America.
Lewitus E; U.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America.; Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, Maryland, United States of America.
Kavusak E; U.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America.; Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, Maryland, United States of America.
Heller J; U.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America.; Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, Maryland, United States of America.
Molnar S; U.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America.; Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, Maryland, United States of America.
Rao M; U.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America.; Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, Maryland, United States of America.
Smith G; U.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America.; Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, Maryland, United States of America.
Bose M; U.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America.; Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, Maryland, United States of America.
Nguyen A; U.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America.; Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, Maryland, United States of America.
Dhungana A; U.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America.; Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, Maryland, United States of America.
Okada K; U.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America.; Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, Maryland, United States of America.
Parisi K; U.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America.; Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, Maryland, United States of America.
Silas D; U.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America.; Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, Maryland, United States of America.
Slike B; U.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America.; Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, Maryland, United States of America.
Ganesan A; Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, Maryland, United States of America.; Infectious Disease Clinical Research Program, Department of Preventive Medicine and Biostatistics, Uniformed Services University of the Health Sciences, Bethesda, Maryland, United States of America.; Walter Reed National Military Medical Center, Bethesda, Maryland, United States of America.
Okulicz J; Infectious Disease Clinical Research Program, Department of Preventive Medicine and Biostatistics, Uniformed Services University of the Health Sciences, Bethesda, Maryland, United States of America.; Brooke Army Medical Center, Fort Sam Houston, San Antonio, Texas, United States of America.
Lalani T; Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, Maryland, United States of America.; Infectious Disease Clinical Research Program, Department of Preventive Medicine and Biostatistics, Uniformed Services University of the Health Sciences, Bethesda, Maryland, United States of America.; Naval Medical Center Portsmouth, Portsmouth, Virginia, United States of America.
Agan BK; Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, Maryland, United States of America.; Infectious Disease Clinical Research Program, Department of Preventive Medicine and Biostatistics, Uniformed Services University of the Health Sciences, Bethesda, Maryland, United States of America.
Crowell TA; U.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America.; Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, Maryland, United States of America.
Darden J; Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, Maryland, United States of America.; Diagnostics and Countermeasures Branch, Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America.
Rolland M; U.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America.; Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, Maryland, United States of America.
Vasan S; U.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America.; Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, Maryland, United States of America.
Ake J; U.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America.
Krebs SJ; U.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America.
Peel S; Diagnostics and Countermeasures Branch, Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America.
Tovanabutra S; U.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America.; Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, Maryland, United States of America.
Polonis VR; U.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America.
Pokaż więcej
Źródło:
PLoS pathogens [PLoS Pathog] 2023 Dec 06; Vol. 19 (12), pp. e1011780. Date of Electronic Publication: 2023 Dec 06 (Print Publication: 2023).
Typ publikacji:
Meta-Analysis; Journal Article
MeSH Terms:
HIV Infections*
HIV-1*/genetics
HIV Seropositivity*
Humans ; United States/epidemiology ; HIV Antibodies ; Neutralization Tests ; env Gene Products, Human Immunodeficiency Virus/genetics ; Antibodies, Neutralizing ; Pandemics
Czasopismo naukowe
Tytuł:
Development of a neutralization monoclonal antibody with a broad neutralizing effect against SARS-CoV-2 variants.
Autorzy:
Ko HL; Division of Research Program, Scripps Korea Antibody Institute, Chuncheon, 24341, Republic of Korea.; Department of Microbiology, College of Medical Science, Kangwon National University, Chuncheon-si, Gangwon-do, 24341, South Korea.
Lee DK; Division of Research Program, Scripps Korea Antibody Institute, Chuncheon, 24341, Republic of Korea.; Department of Microbiology, College of Medical Science, Kangwon National University, Chuncheon-si, Gangwon-do, 24341, South Korea.
Kim Y; Division of Research Program, Scripps Korea Antibody Institute, Chuncheon, 24341, Republic of Korea.; Department of Microbiology, College of Medical Science, Kangwon National University, Chuncheon-si, Gangwon-do, 24341, South Korea.
Jang HJ; Department of Nuclear Medicine, Seoul National University Bundang Hospital, Seongnam-si, Gyeonggi-do, 13620, South Korea.
Lee YW; Department of Nuclear Medicine, Seoul National University Bundang Hospital, Seongnam-si, Gyeonggi-do, 13620, South Korea.
Lee HY; Department of Nuclear Medicine, Seoul National University Bundang Hospital, Seongnam-si, Gyeonggi-do, 13620, South Korea.
Seok SH; Division of Biomedical Convergence, College of Biomedical Science, Kangwon National University, Chuncheon-si, Gangwon-do, 24341, South Korea.
Park JW; Division of Biomedical Convergence, College of Biomedical Science, Kangwon National University, Chuncheon-si, Gangwon-do, 24341, South Korea.
Limb JK; Korea Mouse Phenotyping Center (KMPC), Seoul National University, Seoul, 08826, South Korea.
On DI; Korea Mouse Phenotyping Center (KMPC), Seoul National University, Seoul, 08826, South Korea.; Laboratory of Developmental Biology and Genomics, Research Institute for Veterinary Science, and BK21 Program for Veterinary Science, College of Veterinary Medicine, Seoul National University, Seoul, 08826, South Korea.
Yun JW; Laboratory of Veterinary Toxicology, College of Veterinary Medicine, Seoul National University, Seoul, 08826, South Korea.
Lyoo KS; College of Veterinary Medicine, Jeonbuk National University, Iksan, 54596, Republic of Korea.
Song D; Department of Veterinary Medicine Virology Laboratory, College of Veterinary Medicine and Research Institute for Veterinary Science, Seoul National University, Seoul, 08826, Republic of Korea.
Yeom M; Department of Veterinary Medicine Virology Laboratory, College of Veterinary Medicine and Research Institute for Veterinary Science, Seoul National University, Seoul, 08826, Republic of Korea.
Lee H; Department of Veterinary Medicine Virology Laboratory, College of Veterinary Medicine and Research Institute for Veterinary Science, Seoul National University, Seoul, 08826, Republic of Korea.
Seong JK; Korea Mouse Phenotyping Center (KMPC), Seoul National University, Seoul, 08826, South Korea. .; Laboratory of Developmental Biology and Genomics, Research Institute for Veterinary Science, and BK21 Program for Veterinary Science, College of Veterinary Medicine, Seoul National University, Seoul, 08826, South Korea. .; Interdisciplinary Program for Bioinformatics, Program for Cancer Biology and BIO-MAX/N-Bio Institute, Seoul National University, Seoul, 08826, South Korea. .
Lee S; Division of Research Program, Scripps Korea Antibody Institute, Chuncheon, 24341, Republic of Korea. .
Pokaż więcej
Źródło:
Virology journal [Virol J] 2023 Dec 01; Vol. 20 (1), pp. 285. Date of Electronic Publication: 2023 Dec 01.
Typ publikacji:
Journal Article
MeSH Terms:
SARS-CoV-2*/genetics
COVID-19*
Humans ; Antibodies, Monoclonal ; Neutralization Tests ; Receptors, Virus/metabolism ; Antibodies, Neutralizing ; Antibodies, Viral ; Spike Glycoprotein, Coronavirus/chemistry
SCR Organism:
SARS-CoV-2 variants
Czasopismo naukowe
Tytuł:
Development of a novel medium throughput flow-cytometry based micro-neutralisation test for SARS-CoV-2 with applications in clinical vaccine trials and antibody screening.
Autorzy:
O'Reilly S; Centre for Experimental Pathogen Host Research (CEPHR), University College Dublin, Belfield, Dublin, Ireland.; School of Medicine, University College Dublin, Belfield, Dublin, Ireland.
Kenny G; Centre for Experimental Pathogen Host Research (CEPHR), University College Dublin, Belfield, Dublin, Ireland.; School of Medicine, University College Dublin, Belfield, Dublin, Ireland.; Department of Infectious Diseases, St Vincent's University Hospital, Elm Park, Dublin, Ireland.
Alrawahneh T; Centre for Experimental Pathogen Host Research (CEPHR), University College Dublin, Belfield, Dublin, Ireland.; School of Medicine, University College Dublin, Belfield, Dublin, Ireland.
Francois N; Centre for Experimental Pathogen Host Research (CEPHR), University College Dublin, Belfield, Dublin, Ireland.; School of Medicine, University College Dublin, Belfield, Dublin, Ireland.
Gu L; Centre for Experimental Pathogen Host Research (CEPHR), University College Dublin, Belfield, Dublin, Ireland.; School of Medicine, University College Dublin, Belfield, Dublin, Ireland.
Angeliadis M; Centre for Experimental Pathogen Host Research (CEPHR), University College Dublin, Belfield, Dublin, Ireland.; School of Medicine, University College Dublin, Belfield, Dublin, Ireland.
de Masson d'Autume V; Centre for Experimental Pathogen Host Research (CEPHR), University College Dublin, Belfield, Dublin, Ireland.; School of Medicine, University College Dublin, Belfield, Dublin, Ireland.
Garcia Leon A; Centre for Experimental Pathogen Host Research (CEPHR), University College Dublin, Belfield, Dublin, Ireland.; School of Medicine, University College Dublin, Belfield, Dublin, Ireland.
Feeney ER; Centre for Experimental Pathogen Host Research (CEPHR), University College Dublin, Belfield, Dublin, Ireland.; School of Medicine, University College Dublin, Belfield, Dublin, Ireland.; Department of Infectious Diseases, St Vincent's University Hospital, Elm Park, Dublin, Ireland.
Yousif O; Endocrinology Department, Wexford General Hospital, Carricklawn, Wexford, Ireland.
Cotter A; Centre for Experimental Pathogen Host Research (CEPHR), University College Dublin, Belfield, Dublin, Ireland.; School of Medicine, University College Dublin, Belfield, Dublin, Ireland.; Department of Infectious Diseases, Mater Misericordiae University Hospital, Eccles St, Dublin, Ireland.
de Barra E; Department of Infectious Diseases, Beaumont Hospital, Beaumont, Dublin, Ireland.; Department of International Health and Tropical Medicine, Royal College of Surgeons in Ireland, Dublin, Ireland.
Horgan M; Department of Infectious Diseases, Cork University Hospital, Wilton, Cork, Ireland.
Mallon PWG; Centre for Experimental Pathogen Host Research (CEPHR), University College Dublin, Belfield, Dublin, Ireland.; School of Medicine, University College Dublin, Belfield, Dublin, Ireland.; Department of Infectious Diseases, St Vincent's University Hospital, Elm Park, Dublin, Ireland.
Gautier V; Centre for Experimental Pathogen Host Research (CEPHR), University College Dublin, Belfield, Dublin, Ireland.; School of Medicine, University College Dublin, Belfield, Dublin, Ireland.; Conway Institute of Biomedical and Biomolecular Research, University College Dublin, Belfield, Dublin 4, Ireland.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2023 Nov 30; Vol. 18 (11), pp. e0294262. Date of Electronic Publication: 2023 Nov 30 (Print Publication: 2023).
Typ publikacji:
Journal Article
MeSH Terms:
COVID-19*
Vaccines*
Humans ; Flow Cytometry ; SARS-CoV-2 ; Neutralization Tests ; Antibodies, Neutralizing ; Antibodies, Viral
Czasopismo naukowe
Tytuł:
Development of a Cell-Based SARS-CoV-2 Pseudovirus Neutralization Assay Using Imaging and Flow Cytometry Analysis.
Autorzy:
Izac JR; Biosystems and Biomaterials Division, National Institute of Standards and Technology (NIST), Gaithersburg, MD 20899, USA.
Kwee EJ; Biosystems and Biomaterials Division, National Institute of Standards and Technology (NIST), Gaithersburg, MD 20899, USA.
Tian L; Biosystems and Biomaterials Division, National Institute of Standards and Technology (NIST), Gaithersburg, MD 20899, USA.
Elsheikh E; Biosystems and Biomaterials Division, National Institute of Standards and Technology (NIST), Gaithersburg, MD 20899, USA.
Gaigalas AK; Biosystems and Biomaterials Division, National Institute of Standards and Technology (NIST), Gaithersburg, MD 20899, USA.
Elliott JT; Biosystems and Biomaterials Division, National Institute of Standards and Technology (NIST), Gaithersburg, MD 20899, USA.
Wang L; Biosystems and Biomaterials Division, National Institute of Standards and Technology (NIST), Gaithersburg, MD 20899, USA.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2023 Aug 02; Vol. 24 (15). Date of Electronic Publication: 2023 Aug 02.
Typ publikacji:
Journal Article
MeSH Terms:
SARS-CoV-2*
COVID-19*
Humans ; Flow Cytometry ; Antibodies, Viral ; Neutralization Tests/methods ; Antibodies, Neutralizing
Czasopismo naukowe
Tytuł:
Body Temperature Drop as a Humane Endpoint in Snake Venom-Lethality Neutralization Tests.
Autorzy:
De Jesus, Rosa (AUTHOR)
Tratner, Adam E. (AUTHOR)
Madrid, Alanna (AUTHOR)
Rivera-Mondragón, Andrés (AUTHOR)
Navas, Goy E. (AUTHOR)
Lleonart, Ricardo (AUTHOR)
Britton, Gabrielle B. (AUTHOR)
Fernández, Patricia L. (AUTHOR)
Pokaż więcej
Źródło:
Toxins. Sep2023, Vol. 15 Issue 9, p525. 12p.
Czasopismo naukowe
Tytuł:
Combining MOE Bioinformatics Analysis and In Vitro Pseudovirus Neutralization Assays to Predict the Neutralizing Ability of CV30 Monoclonal Antibody on SARS-CoV-2 Variants.
Autorzy:
Zhu Y; School of Public Health, Sun Yat-Sen University, Guangzhou 510080, China.
Xiong H; School of Public Health, Sun Yat-Sen University, Guangzhou 510080, China.
Liu S; School of Public Health, Sun Yat-Sen University, Guangzhou 510080, China.
Wu D; School of Public Health, Sun Yat-Sen University, Guangzhou 510080, China.
Zhang X; Department of Microbiology Laboratory, Shenzhen Center for Disease Control and Prevention, Shenzhen 518055, China.
Shi X; Department of Microbiology Laboratory, Shenzhen Center for Disease Control and Prevention, Shenzhen 518055, China.
Qu J; Department of Microbiology Laboratory, Shenzhen Center for Disease Control and Prevention, Shenzhen 518055, China.
Chen L; Department of Microbiology Laboratory, Shenzhen Center for Disease Control and Prevention, Shenzhen 518055, China.
Liu Z; Kobilka Institute of Innovative Drug Discovery, School of Medicine, Chinese University of Hong Kong, Shenzhen 518172, China.
Peng B; Department of Microbiology Laboratory, Shenzhen Center for Disease Control and Prevention, Shenzhen 518055, China.
Zhang D; School of Public Health, Sun Yat-Sen University, Guangzhou 510080, China.; NMPA Key Laboratory for Quality Monitoring and Evaluation of Vaccines and Biological Products, Guangzhou 510080, China.
Pokaż więcej
Źródło:
Viruses [Viruses] 2023 Jul 17; Vol. 15 (7). Date of Electronic Publication: 2023 Jul 17.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
COVID-19*
RNA Viruses*
Humans ; SARS-CoV-2/genetics ; Antibodies, Monoclonal ; Computational Biology ; Neutralization Tests ; Antibodies, Neutralizing ; Antibodies, Viral ; Spike Glycoprotein, Coronavirus
SCR Organism:
SARS-CoV-2 variants
Czasopismo naukowe
Tytuł:
SARS-CoV-2 enzyme-linked immunosorbent assays as proxies for plaque reduction neutralisation tests.
Autorzy:
Kay GA; Centre for Drugs and Diagnostics, Liverpool School of Tropical Medicine, Liverpool, UK.; Departments of Vector Biology and Tropical Disease Biology, Centre for Neglected Tropical Diseases, Liverpool School of Tropical Medicine, Liverpool, UK.
Owen SI; Centre for Drugs and Diagnostics, Liverpool School of Tropical Medicine, Liverpool, UK.
Giorgi E; Centre for Health Informatics Computing and Statistics, Lancaster University Medical School, Lancaster University, Lancaster, UK.
Clark DJ; Centre for Diagnostics & Antimicrobial Resistance, Clinical Academic Group in Institute for Infection & Immunity, St George's University of London, London, UK.
Williams CT; Centre for Drugs and Diagnostics, Liverpool School of Tropical Medicine, Liverpool, UK.
Menzies S; Centre for Drugs and Diagnostics, Liverpool School of Tropical Medicine, Liverpool, UK.
Cuevas LE; Centre for Drugs and Diagnostics, Liverpool School of Tropical Medicine, Liverpool, UK.
Davies BMO; Centre for Diagnostics & Antimicrobial Resistance, Clinical Academic Group in Institute for Infection & Immunity, St George's University of London, London, UK.
Eckersley NM; Centre for Diagnostics & Antimicrobial Resistance, Clinical Academic Group in Institute for Infection & Immunity, St George's University of London, London, UK.
Hughes GL; Departments of Vector Biology and Tropical Disease Biology, Centre for Neglected Tropical Diseases, Liverpool School of Tropical Medicine, Liverpool, UK.
Kirwan DE; Centre for Diagnostics & Antimicrobial Resistance, Clinical Academic Group in Institute for Infection & Immunity, St George's University of London, London, UK.
Krishna S; Centre for Diagnostics & Antimicrobial Resistance, Clinical Academic Group in Institute for Infection & Immunity, St George's University of London, London, UK.; St George's University Hospitals NHS Foundation Trust, London, UK.; Institut für Tropenmedizin, Universitätsklinikum Tübingen, Tübingen, Germany.; Centre de Recherches Médicales de Lambaréné, Lambaréné, Gabon.
Patterson EI; Departments of Vector Biology and Tropical Disease Biology, Centre for Neglected Tropical Diseases, Liverpool School of Tropical Medicine, Liverpool, UK.; Department of Biological Sciences, Brock University, St. Catharines, Canada.
Planche T; Centre for Diagnostics & Antimicrobial Resistance, Clinical Academic Group in Institute for Infection & Immunity, St George's University of London, London, UK.; St George's University Hospitals NHS Foundation Trust, London, UK.
Staines HM; Centre for Diagnostics & Antimicrobial Resistance, Clinical Academic Group in Institute for Infection & Immunity, St George's University of London, London, UK. .
Adams ER; Centre for Drugs and Diagnostics, Liverpool School of Tropical Medicine, Liverpool, UK. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2022 Mar 01; Vol. 12 (1), pp. 3351. Date of Electronic Publication: 2022 Mar 01.
Typ publikacji:
Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Neutralization Tests*
Antibodies, Viral/*immunology
COVID-19/*immunology
Immunoglobulin G/*immunology
Immunoglobulin M/*immunology
SARS-CoV-2/*immunology
Spike Glycoprotein, Coronavirus/*immunology
Aged ; Enzyme-Linked Immunosorbent Assay ; Female ; Humans ; Male ; Middle Aged
Czasopismo naukowe
Tytuł:
Poor neutralization and rapid decay of antibodies to SARS-CoV-2 variants in vaccinated dialysis patients.
Autorzy:
Bassi J; Humabs BioMed SA, A Subsidiary of Vir Biotechnology, Bellinzona, Switzerland.
Giannini O; Faculty of Biomedical Sciences, Università della Svizzera italiana, Lugano, Switzerland.; Department of Medicine, Ente Ospedaliero Cantonale, Bellinzona, Switzerland.
Silacci-Fregni C; Humabs BioMed SA, A Subsidiary of Vir Biotechnology, Bellinzona, Switzerland.
Pertusini L; Division of Nephrology, Ente Ospedaliero Cantonale, Lugano, Switzerland.
Hitz P; Faculty of Biomedical Sciences, Università della Svizzera italiana, Lugano, Switzerland.
Terrot T; Clinical Trial Unit, Ente Ospedaliero Cantonale, Lugano, Switzerland.
Franzosi Y; Clinical Trial Unit, Ente Ospedaliero Cantonale, Lugano, Switzerland.
Muoio F; Humabs BioMed SA, A Subsidiary of Vir Biotechnology, Bellinzona, Switzerland.
Saliba C; Humabs BioMed SA, A Subsidiary of Vir Biotechnology, Bellinzona, Switzerland.
Meury M; Vir Biotechnology, San Francisco, California, United States of America.
Dellota EA Jr; Vir Biotechnology, San Francisco, California, United States of America.
Dillen JR; Vir Biotechnology, San Francisco, California, United States of America.
Hernandez P; Vir Biotechnology, San Francisco, California, United States of America.
Czudnochowski N; Vir Biotechnology, San Francisco, California, United States of America.
Cameroni E; Humabs BioMed SA, A Subsidiary of Vir Biotechnology, Bellinzona, Switzerland.
Beria N; Division of Nephrology, Ente Ospedaliero Cantonale, Lugano, Switzerland.
Ventresca M; Division of Nephrology, Ente Ospedaliero Cantonale, Lugano, Switzerland.
Badellino A; Division of Nephrology, Ente Ospedaliero Cantonale, Lugano, Switzerland.
Lavorato-Hadjeres S; Division of Nephrology, Ente Ospedaliero Cantonale, Lugano, Switzerland.
Lecchi E; Division of Nephrology, Ente Ospedaliero Cantonale, Lugano, Switzerland.
Bonora T; Division of Nephrology, Ente Ospedaliero Cantonale, Lugano, Switzerland.
Mattiolo M; Division of Nephrology, Ente Ospedaliero Cantonale, Lugano, Switzerland.
Trinci G; Division of Nephrology, Ente Ospedaliero Cantonale, Lugano, Switzerland.
Garzoni D; Division of Nephrology, Ente Ospedaliero Cantonale, Lugano, Switzerland.
Bonforte G; Division of Nephrology, Ente Ospedaliero Cantonale, Lugano, Switzerland.
Forni-Ogna V; Division of Nephrology, Ente Ospedaliero Cantonale, Lugano, Switzerland.
Giunzioni D; Division of Nephrology, Ente Ospedaliero Cantonale, Lugano, Switzerland.
Berwert L; Division of Nephrology, Ente Ospedaliero Cantonale, Lugano, Switzerland.
Gupta RK; Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Cambridge, United Kingdom.; Department of Medicine, University of Cambridge, Cambridge, United Kingdom.
Ferrari P; Faculty of Biomedical Sciences, Università della Svizzera italiana, Lugano, Switzerland.; Division of Nephrology, Ente Ospedaliero Cantonale, Lugano, Switzerland.; Clinical School, University of New South Wales, Sydney, Australia.
Ceschi A; Faculty of Biomedical Sciences, Università della Svizzera italiana, Lugano, Switzerland.; Clinical Trial Unit, Ente Ospedaliero Cantonale, Lugano, Switzerland.; Division of Clinical Pharmacology and Toxicology, Institute of Pharmacological Science of Southern Switzerland, Ente Ospedaliero Cantonale, Lugano, Switzerland.; Department of Clinical Pharmacology and Toxicology, University Hospital Zurich, Zurich, Switzerland.
Cippà P; Department of Medicine, Ente Ospedaliero Cantonale, Bellinzona, Switzerland.; Division of Nephrology, Ente Ospedaliero Cantonale, Lugano, Switzerland.; Faculty of Medicine, University of Zurich, Zurich, Switzerland.
Corti D; Humabs BioMed SA, A Subsidiary of Vir Biotechnology, Bellinzona, Switzerland.
Lanzavecchia A; Humabs BioMed SA, A Subsidiary of Vir Biotechnology, Bellinzona, Switzerland.
Piccoli L; Humabs BioMed SA, A Subsidiary of Vir Biotechnology, Bellinzona, Switzerland.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2022 Feb 10; Vol. 17 (2), pp. e0263328. Date of Electronic Publication: 2022 Feb 10 (Print Publication: 2022).
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Neutralization Tests*
Renal Dialysis*
Vaccination*
Antibodies, Neutralizing/*immunology
SARS-CoV-2/*immunology
Animals ; Antibodies, Neutralizing/blood ; Antibody Affinity ; CHO Cells ; COVID-19 Vaccines/immunology ; Case-Control Studies ; Cricetulus ; Dose-Response Relationship, Immunologic ; Follow-Up Studies ; HEK293 Cells ; Humans ; Immunoglobulin G/blood ; Risk Factors ; mRNA Vaccines/immunology
SCR Organism:
SARS-CoV-2 variants
Czasopismo naukowe
Tytuł:
Immuno-Colorimetric Neutralization Test: A Surrogate for Widely Used Plaque Reduction Neutralization Tests in Public Health Virology.
Autorzy:
Vaidya SR; Virus Registry and Virus Repository, ICMR-National Institute of Virology, 20-A Dr. Ambedkar Road, Pune 411001, India.
Pokaż więcej
Źródło:
Viruses [Viruses] 2023 Apr 10; Vol. 15 (4). Date of Electronic Publication: 2023 Apr 10.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Antibodies, Viral*
Public Health*
Animals ; Chlorocebus aethiops ; Neutralization Tests ; Vero Cells ; Antibodies, Neutralizing
Czasopismo naukowe
Tytuł:
Calibration of two validated SARS-CoV-2 pseudovirus neutralization assays for COVID-19 vaccine evaluation.
Autorzy:
Huang Y; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA. .; Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA. .; Department of Global Health, University of Washington, Seattle, WA, USA. .
Borisov O; Biomedical Advanced Research and Development Authority, Washington, DC, USA.
Kee JJ; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Carpp LN; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Wrin T; LabCorp-Monogram Biosciences, South San Francisco, CA, USA.
Cai S; LabCorp-Monogram Biosciences, South San Francisco, CA, USA.
Sarzotti-Kelsoe M; Department of Surgery, Duke University Medical Center, Durham, NC, USA.; Department of Immunology, Duke University Medical Center, Durham, NC, USA.
McDanal C; Department of Surgery, Duke University Medical Center, Durham, NC, USA.
Eaton A; Department of Surgery, Duke University Medical Center, Durham, NC, USA.
Pajon R; Moderna, Inc., Cambridge, MA, USA.
Hural J; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Posavad CM; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Gill K; Desmond Tutu HIV Centre, University of Cape Town, Cape Town, South Africa.
Karuna S; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Corey L; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, USA.
McElrath MJ; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.; Departments of Medicine and Laboratory Medicine, University of Washington, Seattle, WA, USA.
Gilbert PB; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.; Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.; Department of Biostatistics, University of Washington, Seattle, WA, USA.
Petropoulos CJ; LabCorp-Monogram Biosciences, South San Francisco, CA, USA.
Montefiori DC; Department of Surgery, Duke University Medical Center, Durham, NC, USA. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2021 Dec 14; Vol. 11 (1), pp. 23921. Date of Electronic Publication: 2021 Dec 14.
Typ publikacji:
Comparative Study; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Antibodies, Neutralizing/*blood
COVID-19/*immunology
Neutralization Tests/*standards
SARS-CoV-2/*immunology
2019-nCoV Vaccine mRNA-1273/immunology ; Antibodies, Viral/blood ; COVID-19/blood ; Clinical Decision-Making ; Clinical Trials as Topic ; Diagnostic Tests, Routine ; Humans ; Neutralization Tests/methods ; World Health Organization
Czasopismo naukowe
Tytuł:
Detection of SARS-CoV-2 Antibodies: Comparison of Enzyme Immunoassay, Surrogate Neutralization and Virus Neutralization Test.
Autorzy:
Vilibic-Cavlek, Tatjana (AUTHOR)
Bogdanic, Maja (AUTHOR)
Borko, Ema (AUTHOR)
Hruskar, Zeljka (AUTHOR)
Zilic, Denis (AUTHOR)
Ferenc, Thomas (AUTHOR)
Tabain, Irena (AUTHOR)
Barbic, Ljubo (AUTHOR)
Vujica Ferenc, Mateja (AUTHOR)
Ferencak, Ivana (AUTHOR)
Stevanovic, Vladimir (AUTHOR)
Pokaż więcej
Źródło:
Antibodies (2073-4468). Jun2023, Vol. 12 Issue 2, p35. 9p.
Czasopismo naukowe
Tytuł:
Comparison of measles IgG enzyme immunoassays (EIA) versus plaque reduction neutralization test (PRNT) for measuring measles serostatus: a systematic review of head-to-head analyses of measles IgG EIA and PRNT.
Autorzy:
Lutz, Chelsea S. (AUTHOR)
Hasan, Alvira Z. (AUTHOR)
Bolotin, Shelly (AUTHOR)
Crowcroft, Natasha S. (AUTHOR)
Cutts, Felicity T. (AUTHOR)
Joh, Eugene (AUTHOR)
Loisate, Stacie (AUTHOR)
Moss, William J. (AUTHOR)
Osman, Selma (AUTHOR)
Hayford, Kyla (AUTHOR)
Pokaż więcej
Źródło:
BMC Infectious Diseases. 5/31/2023, Vol. 23 Issue 1, p1-18. 18p.
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies